FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

879511000001105: Camcolit 250 tablets (Norgine Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17432701000001119 Camcolit 250 tablets (Norgine Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17432801000001111 Camcolit 250 tablets (Norgine Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
37845101000001117 Camcolit 250 tablets (Norgine Pharmaceuticals Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
83787001000001118 Camcolit 250 tablets (Essential Pharma Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Camcolit 250 tablets (Norgine Ltd) Is a Product containing precisely lithium carbonate 250 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Camcolit 250 tablets (Norgine Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Camcolit 250 tablets (Norgine Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Camcolit 250 tablets (Norgine Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Camcolit 250 tablets (Norgine Ltd) Has active ingredient Lithium carbonate false Inferred relationship Existential restriction modifier
Camcolit 250 tablets (Norgine Ltd) VMP prescribing status (attribute) Not recommended to prescribe as a VMP false Inferred relationship Existential restriction modifier
Camcolit 250 tablets (Norgine Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Camcolit 250 tablets (Norgine Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Camcolit 250 tablets (Norgine Ltd) Is a Camcolit true Inferred relationship Existential restriction modifier
Camcolit 250 tablets (Norgine Ltd) Has specific active ingredient Lithium carbonate true Inferred relationship Existential restriction modifier
Camcolit 250 tablets (Norgine Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Camcolit 250 tablets (Norgine Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Camcolit 250 tablets (Norgine Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Camcolit 250 tablets (Norgine Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Camcolit 250 tablets (Norgine Ltd) 100 tablet Is pack of False Camcolit 250 tablets (Norgine Ltd) Inferred relationship Existential restriction modifier
Camcolit 250 tablets (Norgine Ltd) 100 tablet Has AMP True Camcolit 250 tablets (Norgine Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start